ArticleBMJ open2022

Protocol for a 30-day randomised, parallel-group, non-inferiority, controlled trial investigating the effects of discontinuing renin-angiotensin system inhibitors in patients with and without COVID-19: the RASCOVID-19 trial.

Vivian Kliim-Hansen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.